Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: J Vasc Surg. 2009 May;49(5):1296–1303. doi: 10.1016/j.jvs.2008.12.026

Figure 5.

Figure 5

ATF (10nM) induced EGFR phosphorylation which was inhibited by the matrix metalloprotease inhibitor (GM6001) and the A Disintegrin And Metalloproteinase Domains (ADAM) inhibitors (TAPI-0 and TAPI-1). Values are the mean±SEM of the ratio of the phosphorylation of EGFR relative to the total unphosphosphorylated EGFR (n=6, *p<0.05 **p<0.01 compared to control). Representative Western blots are shown above the graphs.